In October, CHERISH researchers and colleagues are heading abroad and across the states to share their latest research on harm reduction, syringe service programs, and HIV and HCV treatment.
Overseas, researchers are attending the 13th National Harm Reduction Conference in San Juan, Puerto Rico, and the 10th International Conference on Health and Hepatitis Care in Substance Users (INHSU) in Glasgow, Scotland. Presenters include Cristina Chin, research manager within the Department of Population Health Sciences at Weill Cornell Medicine; CHERISH Research Affiliates Xiao Zang, Shashi Kapadia, Czarina Behrends, Natasha Martin, and Tyler Bartholomew; and CHERISH investigator Alexander Walley.
In the states, CHERISH researchers and colleagues will make appearances at the 2022 Polysubstance Use Symposium in New York City, the American Public Health Association 2022 Annual Meeting in Boston, and the Society for Medical Decision Making (SMDM) 44th Annual North American Meeting in Seattle. Look out for CHERISH Research Affiliates Thanh Lu, Xiao Zang, and Ali Jalali; Danielle Ryan, senior research coordinator in the Division of Comparative Effectiveness and Outcomes Research at Weill Cornell Medicine; and Erminia Fardone, assistant scientist at the University of Miami Miller School of Medicine.
Learn more about their presentations below.
The 13th National Harm Reduction Conference
Presented by the National Harm Reduction Coalition
October 13 – 16, 2022, San Juan, Puerto Rico
#HARMRED22
12:00 – 2:00
Poster Session #1
Comparing projected fatal overdose outcomes and costs of strategies to expand naloxone distribution: A modeling study of community-based distribution in Rhode Island
- Presenter: Xiao Zang, PhD
12:00 – 2:00
Poster Session #3
Harm Reduction and Clinical Patient Needs of REACH Medical’s Low-Threshold Buprenorphine Clinic
- Presenter: Cristina Chin, LMSW
The 10th International Conference on Health and Hepatitis Care in Substance Users (INHSU)
October 19 – 21, 2022, Glasgow, Scotland, United Kingdom
#INHSU2022
Day 1 Program (BST)
Poster Tour 02: Data, Data, Data
15.55 – 16.00 Development and validation of a global model to optimize HIV resource allocation among people who inject drugs: The intrepid model
- Presenter: Natasha Martin, DPhil
Day 2 Program (BST)
Session K: Elimination of Hepatitis C infection: Where are we now and what is possible?
09.00 – 09.20 HCV elimination among people who inject drugs – Where are we now and where to from here?
- Presenter: Natasha Martin, DPhil
Session O: Oral Abstract Session: Striving towards HCV elimination
14.50 – 14.55 “Treated like a Human Being”: Perspectives of people who inject drugs attending low-threshold HCV treatment at a syringe service program in New York City.
- Presenter: Shashi Kapadia, MD, MS
Day 3 Program (BST)
Poster Tour 03: Integrated Care Strategies/Models
11.25 – 11.30 Rapid Hepatitis C Treatment Initiation in Young People who Inject Drugs: Final Results From The HCV-Seek, Test & Rapid Treatment (HCV-ST&RT) Randomized Pilot Clinical Trial.
- Presenter: Benjamin Eckhardt, MD
Session V Abstract Session: Treatment of HCV infection among PWID
12.00 – 12.15 Accessible HCV care for people who inject drugs: Randomized clinical trial comparing low-threshold treatment at a syringe service program versus facilitated referral.
- Presenter: Benjamin Eckhardt, MD
Poster Presentations
Addressing Drug Related Harms
Post-Overdose Outreach Programs in Massachusetts: Lessons Learned, Impact and Best Practice Guidance
- Speaker: Alexander Walley, MD, MSc
Application of Machine Learning Algorithms For Localized Syringe Services Program Policy Implementation – Florida, 2017
- Speaker: Tyler Bartholomew, PhD
Unit Costs of Needle and Syringe Program Provision: A Global Systematic Review and Cost Extrapolation
- Speaker: Natasha Martin, DPhil
Drug Use Trends
Injection Drug Use Patterns and Changes Associated With HCV Treatment
- Speaker: Benjamin Eckhardt, MD
HCV Epidemiology
Disparities in Hepatitis C Treatment Uptake Among U.S. Medicaid Enrollees in 2018: Analysis of National Administrative Data
- Speaker: Shashi Kapadia, MD, MS
Services for People Who Use Drugs
Impact of State HIV and Hepatitis C (HCV) Screening Policies on HIV/HCV Testing Provision at Substance Use Disorder (SUD) Treatment Programs in The United States
- Speaker: Czarina Behrends, PhD, MPH
2022 Polysubstance Use Symposium
Presented by NYU Langone’s Center for Opioid Epidemiology and Policy
October 20 – 21, 2022, New York, NY
4:15 – 6:30 PM (ET)
Poster
A National Profile of Medicaid Enrollees with Stimulant Use Disorder and Risk of Poly-substance Use Disorder: Evidence From 2017-2018 Transformed Medicaid Statistical Information System
- Presenter: Thanh Lu, PhD
Society for Medical Decision Making 44th Annual North American Meeting (SMDM)
October 23 – 26, 2022, Seattle, WA
#SMDM22
18:30 – 20:00 (PT)
Poster Session 1
Comparing projected fatal overdose outcomes and costs of strategies to expand naloxone distribution: A modeling study of community-based distribution in Rhode Island
- Presenter: Xiao Zang, PhD
A method to adjust cost-effectiveness acceptability curves in economic evaluations to account for uncertainty in the correlation between incremental cost and effect outcomes
- Presenter: Ali Jalali, PhD
APHA 2022 Annual Meeting
November 6 – 9, 2022, Boston, MA
#APHA2022
2:30 PM (ET)
Opioids Oral Session #1 Opioid Use Disorder Treatments are Effective but Underutilized. What Are the Factors that Affect Optimization?
3:00 PM Cost of start-up activities required to implement the delivery of medications for opioid use disorder (MOUD) in correctional settings in Massachusetts
- Presenter: Danielle Ryan, MPH
AMERSA 46th Annual Conference
November 10 – 12, 2022, Boston, MA
#AMERSA2022
6:15 – 7:45 PM (ET)
Welcome and Poster Session
6:15 PM Approaches and economic impact of personalized interventions for substance use disorder: A Systematic Literature Review
- Presenter: Erminia Fardone, PhD